Yahoo
Copenhagen - Delayed Quote DKK

Novozymes A/S (NSIS-B.CO)

462.00 -3.30 (-0.71%)
At close: October 30 at 4:59:41 PM GMT+1
Chart Range Bar
Loading chart for NSIS-B.CO
  • Previous Close 465.30
  • Open 468.50
  • Bid 464.80 x --
  • Ask 462.00 x --
  • Day's Range 462.00 - 470.80
  • 52 Week Range 336.80 - 481.50
  • Volume 1,068,313
  • Avg. Volume 610,788
  • Market Cap (intraday) 215.408B
  • Beta (5Y Monthly) 0.62
  • PE Ratio (TTM) 45.47
  • EPS (TTM) 10.16
  • Earnings Date Aug 20, 2026
  • Forward Dividend & Yield 6.60 (1.43%)
  • Ex-Dividend Date Aug 25, 2026
  • 1y Target Est 500.33

Novozymes A/S produces and sells industrial enzymes, functional proteins, and microorganisms in Denmark, rest of Europe, North America, the Asia Pacific, the Middle East, Africa, and Latin America. It provides biosolutions for the food and beverage industry, such as dairy, baking, beverage, meat, plant-based, functional, and other foods, as well as precision protein and early lie nutrition. The company also offers bioenergy solutions including biodiesel; biogas from agricultural and industrial residues and food waste; biomass; carbon capture; ethanol for liquefaction, saccharification, fermentation, and fiber conversion; and renewable diesel. In addition, it provides dishwashing, home cleaning, laundry, medical, and industrial and institutional cleaning services; gastrointestinal, immune, mental, women's, children's cardiometabolic, and oral human health solutions. Further, the company offers corn and wheat separation, liquefaction, saccharification, filtration, isomerization, maltose, and specialties solutions; corn, cotton, forages, peanuts, pulses, soybeans, wheat, small grains, bioyield, and biocontrol solutions; silage, diary and beef cattle, poultry, swine, aquaculture solutions; pet care solutions; leather and textiles solutions; fiber modification, bleach boosting, deposit control, and starch modification solutions; and distilling, oils and fats, sustainable plastic solutions. Additionally, it provides lipases, proteases, oxidoreductases, and carbohydrases. Novozymes A/S is headquartered in Lyngby, Denmark.

www.novonesis.com

10,933

Full Time Employees

December 31

Fiscal Year Ends

Recent News

View More

Performance Overview

Trailing total returns as of 10/30/2026, which may include dividends or other distributions. Benchmark is OMX Copenhagen 25 Index (^OMXC25) .

YTD Return

NSIS-B.CO
13.88%
OMX Copenhagen 25 Index (^OMXC25)
8.24%

1-Year Return

NSIS-B.CO
18.74%
OMX Copenhagen 25 Index (^OMXC25)
15.77%

3-Year Return

NSIS-B.CO
52.28%
OMX Copenhagen 25 Index (^OMXC25)
23.77%

5-Year Return

NSIS-B.CO
5.29%
OMX Copenhagen 25 Index (^OMXC25)
0.16%

Earnings Trends

View More

Earnings Per Share

GAAP
Normalized
GAAP
Normalized

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q2 FY26
Revenue 8.34B
Earnings 1.28B
Profit Margin 15.38%

Q3

FY25

Q4

FY25

Q1

FY26

Q2

FY26

0
2B
4B
6B
8B
13.0%
14.0%
15.0%
16.0%
17.0%

Analyst Insights

View More

Analyst Price Targets

420.00 Low
500.33 Average
462.00 Current
540.00 High

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell

Latest Rating

Date 3/26/2019
Analyst JP Morgan
Rating Action Downgrade
Rating Underweight
Price Action --
Price Target --

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    14.70%

  • Return on Assets (ttm)

    3.79%

  • Return on Equity (ttm)

    5.77%

  • Revenue (ttm)

    4.3B

  • Net Income Avi to Common (ttm)

    631.6M

  • Diluted EPS (ttm)

    10.16

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    308.7M

  • Total Debt/Equity (mrq)

    27.51%

  • Levered Free Cash Flow (ttm)

    726.71M

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: